The EPS projection of Clorox Company (The) (NYSE:CLX) for quarter ended 2016-09-30 is $1.38. Last week, the EPS forecast was $1.38 against target of $1.38, a month earlier. Two months ago, this estimate was $1.38 versus forecast of $1.38 three months earlier, implying a deviation of 0%.
Clorox Company (The) (NYSE:CLX) stated that 18 days ago, its stock price was positively revised 3 times while negative revisions were 0.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 2, 1, and 2, correspondingly.
EPS estimate downgrade for Clorox Company (The) (NYSE:CLX) in the preceding 30, 120, 60 and 90 days were 0, 0, 0, and 0, correspondingly.
Clorox Company (The) (NYSE:CLX) EPS target for the quarter closed 3 was $1.38, based on 7 recommendations. As reported on 2016-05-03 the EPS was $1.21. The change was $0.11, implying a percentage deviation of 10%. The projections showed a standard deviation of 0.03.
Quarterly Sales Estimates
Clorox Company (The) (NYSE:CLX) yearly sales prediction for the fiscal 2017 stands at $1642.212 and the median estimate is at $1643.425. Almost 4 analysts issued sales target.
Highest sales target is $1668 while the lowest target is $1614 showing standard deviation of 22.281%.
As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.
Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast. Clorox Company (The) (NYSE:CLX) announced that the deviation in forecast was 3.243%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...